Drugs / Octaplas
Octaplas
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials | ||||||
| Phase 4 | NCT01938378 | Apr 2015 → Jan 2019 | — | Octapharma | Completed | No outcome recorded |
| Phase 4 | NCT02050841 | Dec 2014 → Dec 2017 | blood coagulation disease, liver disorder | Octapharma | Completed | No outcome recorded |
| Phase 4 | NCT01754545 | Sep → Nov 2012 | congenital thrombotic thrombocytopenic purpura | St. Olavs Hospital | Withdrawn | No outcome recorded Stop: Enrollment |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT06934278 Comparator | May 2025 → Dec 2030 expected | adolescent idiopathic scoliosis | Turku University Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT01910675 Comparator | Jul 2013 → Oct 2018 | — | Helsinki University Central Hospital | Withdrawn | No outcome recorded |
Press releases naming this drug 1 release
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Octaplas | “Objective To compare pooled human plasma (PHP, OCTAPLAS) vs. crystalloid (PLASMALYTE, comparator) for intraoperative bleeding, drain output, and hidden blood loss” NCT06934278 ↗5“Twenty patients in the FFP group receive 4 units of FFP (Octaplas).” NCT01910675 ↗ “Pooled human plasma (Octaplas, 10 mL/kg, max 400 mL)” NCT06934278 ↗ |
| Known as | PHP | “Objective To compare pooled human plasma (PHP, OCTAPLAS) vs. crystalloid (PLASMALYTE, comparator)” NCT06934278 ↗ |
| Known as | pooled human plasma | “Pooled human plasma (Octaplas, 10 mL/kg, max 400 mL)” NCT06934278 ↗ |
| Action | Restore | “replacement of single or multiple coagulation factors” PMID 33042916 ↗ Sep 2020 |
| Modality | Protein / enzyme biologic | “Acute attacks can be treated successfully with infusions of human plasma” NCT01754545 ↗ |
| Route | Intravenous | “Route of administration is intravenously.” NCT01754545 ↗ |